Oral Weight-Loss Drug Will Have Similar Efficacy as Wegovy

Novo Nordisk expects the oral version of its semaglutide drug to treat obesity to have similar efficacy as its Wegovy injection, a senior executive said on Thursday.
Reuters Health Information

source https://www.medscape.com/viewarticle/991558?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost